Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report.
EZH2 gene mutation
Hashimoto’s thyroiditis
Primary follicular lymphoma
Thyroid papillary carcinoma
Journal
Diagnostic pathology
ISSN: 1746-1596
Titre abrégé: Diagn Pathol
Pays: England
ID NLM: 101251558
Informations de publication
Date de publication:
21 May 2024
21 May 2024
Historique:
received:
04
03
2024
accepted:
11
05
2024
medline:
22
5
2024
pubmed:
22
5
2024
entrez:
22
5
2024
Statut:
epublish
Résumé
Papillary thyroid carcinoma (PTC) stands out as the most prevalent epithelial malignant thyroid tumor. Thyroid primary follicular lymphoma (PFL) represents a rare malignant tumor originating from mesenchymal tissues. The concurrent occurrence of PTC and PFL is exceptionally rare, particularly in the context of Hashimoto's thyroiditis, presenting significant challenges in clinical diagnosis and treatment. A 44-year-old female patient presented with a neck mass persisting for over 1 month. The patient underwent surgery, and the incised tissues were subjected to pathology examinations, along with immunohistochemistry and next-generation sequencing tests suggestive of an EZH2 gene mutation in the tumor cells. The final pathological diagnosis confirmed the presence of PTC combined with PFL. Following a 27-month follow-up, the patient displayed no signs of recurrence or metastasis. The concurrent occurrence of PTC and PFL poses notable challenges in clinical practice, requiring careful consideration in diagnosis and treatment. Herein, we present a rare case of PTC combined with PFL featuring an EZH2 gene mutation, which can be easily overlooked in the context of Hashimoto's thyroiditis. The patient's favorable response to surgical and radiotherapeutic interventions underscores the importance of accurate diagnosis and tailored treatment strategies in similar cases.
Sections du résumé
BACKGROUND
BACKGROUND
Papillary thyroid carcinoma (PTC) stands out as the most prevalent epithelial malignant thyroid tumor. Thyroid primary follicular lymphoma (PFL) represents a rare malignant tumor originating from mesenchymal tissues. The concurrent occurrence of PTC and PFL is exceptionally rare, particularly in the context of Hashimoto's thyroiditis, presenting significant challenges in clinical diagnosis and treatment.
CASE DEMONSTRATION
UNASSIGNED
A 44-year-old female patient presented with a neck mass persisting for over 1 month. The patient underwent surgery, and the incised tissues were subjected to pathology examinations, along with immunohistochemistry and next-generation sequencing tests suggestive of an EZH2 gene mutation in the tumor cells. The final pathological diagnosis confirmed the presence of PTC combined with PFL. Following a 27-month follow-up, the patient displayed no signs of recurrence or metastasis.
CONCLUSIONS
CONCLUSIONS
The concurrent occurrence of PTC and PFL poses notable challenges in clinical practice, requiring careful consideration in diagnosis and treatment. Herein, we present a rare case of PTC combined with PFL featuring an EZH2 gene mutation, which can be easily overlooked in the context of Hashimoto's thyroiditis. The patient's favorable response to surgical and radiotherapeutic interventions underscores the importance of accurate diagnosis and tailored treatment strategies in similar cases.
Identifiants
pubmed: 38773600
doi: 10.1186/s13000-024-01495-0
pii: 10.1186/s13000-024-01495-0
doi:
Substances chimiques
EZH2 protein, human
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
69Informations de copyright
© 2024. The Author(s).
Références
Ziaolhagh R, Sadrizadeh A, Shabany BP, et al. A case report of simultaneous medullary and papillary carcinoma of thyroid. Endocr Regul. 2021;55(2):83–8.
doi: 10.2478/enr-2021-0010
pubmed: 34020529
Kossev P, Livolsi V. Lymphoid lesions of the thyroid: review in light of the revised european-american lymphoma classification and upcoming World Health Organization classification. Thyroid. 1999;9(12):1273–80.
doi: 10.1089/thy.1999.9.1273
pubmed: 10646671
Xie S, Liu W, Xiang Y, et al. Primary thyroid diffuse large B-cell lymphoma coexistent with papillary thyroid carcinoma: a case report. Head Neck. 2015;37(9):E109–14.
doi: 10.1002/hed.23917
pubmed: 25352071
Melo GM, Sguilar DA, Petiti CM, et al. Concomitant thyroid Malt lymphoma and papillary thyroid carcinoma. Arq Bras Endocrinol Metab. 2010;54:425–8.
doi: 10.1590/S0004-27302010000400013
Lee JH, Kim Y, Choi JW, et al. The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis. Eur J Endocrinol. 2013;168(3):343–9.
doi: 10.1530/EJE-12-0903
pubmed: 23211578
Kurukahvecioglu O, Taneri F, Yüksel O, et al. Total thyroidectomy for the treatment of Hashimoto’s thyroiditis coexisting with papillary thyroid carcinoma. Adv Therapy. 2007;24:510–6.
doi: 10.1007/BF02848773
Trovato M, Giuffrida G, Seminara A, et al. Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by Hashimoto’s thyroiditis. Arch Endocrinol Metab. 2017;61(6):643–6.
doi: 10.1590/2359-3997000000313
pubmed: 29412392
pmcid: 10522052
Zhang L, Li H, Ji QH, et al. The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease. BMC Cancer. 2012;12:610.
doi: 10.1186/1471-2407-12-610
pubmed: 23256514
pmcid: 3547693
Zhang Y, Dai J, Wu T, et al. The study of the coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma. J Cancer Res Clin Oncol. 2014;140(6):1021–6.
doi: 10.1007/s00432-014-1629-z
pubmed: 24619663
Thieblemont C, Mayer A, Dumontet C, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metabolism. January 2002;87(1):105–11.
Chris M, Bacon MBCB, et al. Follicular Lymphoma of the thyroid GlandAm. J Surg Pathol. 2009;33(1):22–34.
doi: 10.1097/PAS.0b013e31817d7470
Guohua Shen MD, Ting Ji et al. Coexistence of papillary thyroid carcinoma with thyroid MALT lymphoma in a Patient With Hashimoto’s Thyroiditis.
Thieblemont C, Mayer A, Dumontet C, et al. Show morePrimary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metabolism. January 2002;87(1):1.
Chen L, Liu Y, Dong C. Coexistence of primary thyroid diffuse large B cell lymphoma and papillary thyroid carcinoma: a case report and literature review. J Int Med Res. 2019;47(10):5289–93.
doi: 10.1177/0300060519869133
pubmed: 31456463
pmcid: 6833368
Chai YJ, Hong JH, Koo DH, et al. Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid lymphoma: a multicenter study. Ann Surg Treat Res. 2015;89:295.
doi: 10.4174/astr.2015.89.6.295
pubmed: 26665123
pmcid: 4672092
Fatima S, Siddiqui WA, Alshehri A. Primary thyroid lymphoma: case series with review of literature. Indian J Hematol Blood Transfus. 2014;30:346–8.
doi: 10.1007/s12288-014-0400-6
pubmed: 25332615
pmcid: 4192167
Martínez-Laperche C, Sanz-Villanueva L, Díaz Crespo FJ, et al. EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment. BMC Cancer. 2022;22:982.
doi: 10.1186/s12885-022-10070-z
pubmed: 36104682
pmcid: 9476261
Cheung C, Ezzat S, Freeman J, et al. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol. 2001;14:338–42.
doi: 10.1038/modpathol.3880312
pubmed: 11301350
Trovato M, et al. Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by Hashimoto’s thyroiditis. Archives Endocrinol Metabolism. 2017;61:643–6.
doi: 10.1590/2359-3997000000313
Nam YJ, Kim BH, Lee SK, et al. Co-occurrence of papillary thyroid carcinoma and mucosa-associated lymphoid tissue lymphoma in a patient with longstanding hashimoto thyroiditis. Endocrinol Metab (Seoul). 2013;28(4):341–5.
doi: 10.3803/EnM.2013.28.4.341
pubmed: 24396701